Search Medical Condition
Please enter condition
Please choose location from dropdown

Pathumwan, Thailand Clinical Trials

A listing of Pathumwan, Thailand clinical trials actively recruiting patients volunteers.

RESULTS

Found (193) clinical trials

Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults

Previous study has shown the higher immunogenicity response among HIV-infected adults who received a single visit 4-site intradermal rabies booster vaccination than those who received the conventional intramuscular regimen. The investigators follow the persistence of these effects. Also, the regulatory T cell levels were examined after the rabies booster vaccination ...

Phase N/A

0.0 miles

Learn More »

Vaginal Progesterone Supplementation in the Management of Preterm Labor

This study evaluates the addition of vaginal progesterone in the management of preterm labor. Half of participants will receive vaginal progesterone, tocolysis and corticosteroid, while the other half will receive only tocolysis and corticosteroid.

Phase N/A

0.0 miles

Learn More »

A Long-term Follow-up of the HIV-NAT Cohort

Primary Objective: To collect and evaluate long-term clinical outcomes of HIV infected participants previously enrolled in HIV-NAT trials. Secondary Objective: To Assess: Long-term consequences of initiation of antiretroviral as predicted by baseline CD4 cell count and/or baseline plasma HIV RNA level Incidence of lipodystrophy and other metabolic complications in three ...

Phase N/A

0.0 miles

Learn More »

A Prospective Cohort of Children With HIV Infection

This is a long term cohort study that was started in 2002. Currently, there are 120 children enrolled in the study and are receiving HIV care according to standard practice set by the Thai Ministry of Public Health. HIV-infected parents also receive care at the same clinic.

Phase N/A

0.0 miles

Learn More »

Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage

Hordeolum is a common eyelid disease. In case of mass, I&C is required but role of antibiotic after I&C is not clear. It may not need in post drainage period.

Phase

0.0 miles

Learn More »

Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population

This study will establish an acute infection cohort which is predominantly non-subtype B. Description of the early events in HIV infection is critical to HIV vaccine development and understanding HIV-1 immunopathogenesis. The ability to establish this cohort and identify individuals with acute HIV-1 infection would provide the basis for future ...

Phase N/A

0.0 miles

Learn More »

Antiretroviral Therapy for Acute and Chronic HIV Infection

HIV-1 plasma viral RNA measurements and CD4 counts during follow-up and after therapy Number of HIV and non-HIV related clinical events Adverse events related to HAART Adherence to HAART Resistance to antiretroviral medications

Phase

0.0 miles

Learn More »

A Study to Evaluate the Pharmacokinetics Safety Tolerability and Antiviral Efficacy of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

This is a Phase II, open-label (all people involved know the identity of the assigned drug) and single arm study. The study will consist of a screening period of maximum 8 weeks, an initial treatment period of 48 weeks, a post week 48 treatment extension period of 4 years, and ...

Phase

0.0 miles

Learn More »

A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

The purpose of this study is to evaluate the efficacy of the study drug known as ramucirumab in participants with gastric and gastroesophageal cancer.

Phase

0.0 miles

Learn More »

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

This is a first-in-human, two-part, open-label, safety, pharmacokinetic, and efficacy study of oral CK-101 administered daily in ascending doses in patients with advanced solid tumor cancer, followed by a Phase 2 portion at the recommended Phase 2 dose (RP2D) in previously treated non-small cell lung cancer (NSCLC) patients who have ...

Phase

0.0 miles

Learn More »